
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Preclinical
Sponsor : Japan’s Okinawa Research Center
Deal Size : Undisclosed
Deal Type : Partnership
ANEW MEDICAL Partners with Okinawa Research Center to Study Klotho Gene
Details : The collaboration aims to focus on the research and development of ANEW’s patented Klotho gene therapy in enhancing longevity and reducing age-related diseases.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
June 27, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Preclinical
Sponsor : Japan’s Okinawa Research Center
Deal Size : Undisclosed
Deal Type : Partnership

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : Redwoods Acquisition Corp.
Deal Size : Undisclosed
Deal Type : Merger
Anew Medical, Inc. Enters Into Definitive Merger Agreement with Redwoods Acquisition Corp.
Details : ANEW intends to use the proceeds from the transaction to progress its lead gene therapy programs including, Alpha Klotho-based gene therapy being developed for the treatment of amyotrophic lateral sclerosis (ALS) and Alzheimer's disease (AD).
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
May 30, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : Redwoods Acquisition Corp.
Deal Size : Undisclosed
Deal Type : Merger

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Study Phase : Preclinical
Recipient : Universitat Autònoma de Barcelona
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : The α-Klotho gene and protein as its loss and low blood levels is most directly associated with aging and many age-related diseases – the gene is often called "the anti-aging gene".
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
December 07, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Recipient : Universitat Autònoma de Barcelona
Deal Size : Undisclosed
Deal Type : Licensing Agreement
